Updated: CMS releases anticipated state timelines for initiating unwinding-related Medicaid renewals
By
Lois A. Bowers
Mar 02, 2023
The Centers for Medicare & Medicaid Services today posted the anticipated state timelines for initiating unwinding-related Medicaid renewals.
CCRC residents ‘significantly safer’ from COVID deaths than older adults not living in congregate...
By
Lois A. Bowers
Mar 02, 2023
SAN DIEGO—Residents of continuing care retirement communities were “significantly safer” from dying from COVID-19 than were older adults living in noncongregate residential settings in the greater...
Breath analysis shows promise for COVID-19 detection
Feb 28, 2023
High accuracy was seen for four volatile organic compounds, which decreased when the biomarkers were applied to an omicron variant.
Incident CVD, mortality risk heightened for at least one year after COVID-19
Feb 21, 2023
Short- and long-term risks were found in a large study of patients with COVID-19 versus matched contemporary and historical cohorts.
Providers to receive $250,000 for COVID-19 vaccine clinics
By
Kimberly Bonvissuto
Feb 21, 2023
LeadingAge will distribute more than $250,000 in grants to help its members host COVID-19 vaccination clinics to increase vaccination uptake among staff members, residents, family and community members.
Risk for diabetes after COVID-19 still increased during omicron phase
Feb 14, 2023
The risk for new-onset diabetes is significantly elevated during the omicron-dominant phase, but no increase was seen for risks for hypertension or hyperlipidemia.
Practicing physicians saw excess mortality during COVID-19 pandemic
Feb 13, 2023
However, physicians had substantially lower excess mortality than the general U.S. population.
Long-term sequelae specific to SARS-CoV-2 infection identified
Feb 13, 2023
Palpitations, hair loss, fatigue, chest pain, dyspnea, joint pain and obesity were seen after SARS-CoV-2 versus other viral respiratory infections.
Recommended 2023 adult immunization schedule published
Feb 10, 2023
Changes include a new section relating to COVID-19 vaccines and the addition of a newly licensed vaccine for hepatitis B.
Pegylated interferon lambda effective in preventing severe COVID-19
Feb 09, 2023
The incidence of hospitalization or emergency department visit was lower for those receiving interferon versus placebo.